Phase 2 Study of WGI-0301 for Advanced HCC

Clinical trial NCT06309485 · RECRUITING

Trial details

NCT number: NCT06309485
Sponsor: Zhejiang Haichang Biotech Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma (HCC)

Start date: 2024-07-31
Primary completion: 2026-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.